Search Results - "Atilla, Pinar Ataca"

Engineered off-the-shelf therapeutic T cells resist host immune rejection by Mo, Feiyan, Watanabe, Norihiro, McKenna, Mary K., Hicks, M. John, Srinivasan, Madhuwanti, Gomes-Silva, Diogo, Atilla, Erden, Smith, Tyler, Ataca Atilla, Pinar, Ma, Royce, Quach, David, Heslop, Helen E., Brenner, Malcolm K., Mamonkin, Maksim

“…Engineered T cells are effective therapies against a range of malignancies, but current approaches rely on autologous T cells, which are difficult and…”
Get full text

An Overview of Infectious Complications after Allogeneic Hematopoietic Stem Cell Transplantation by Sahin, Ugur, Toprak, Selami Kocak, Ataca Atilla, Pinar, Atilla, Erden, Demirer, Taner, MD, FACP

“…Abstract Infections are the most common and significant cause of mortality and morbidity after allogeneic hematopoietic stem cell transplantation (allo-HSCT)…”
Get full text

New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology by Gunduz, Mehmet, Ataca Atilla, Pinar, Atilla, Erden

“…NK (Natural Killer) cell-mediated adoptive immunotherapy has gained attention in hematology due to the progressing knowledge of NK cell receptor structure,…”
Get full text

Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia by Ataca Atilla, Pinar, McKenna, Mary K, Tashiro, Haruko, Srinivasan, Madhuwanti, Mo, Feiyan, Watanabe, Norihiro, Simons, Brian Wesley, McLean Stevens, Alexandra, Redell, Michele S, Heslop, Helen E, Mamonkin, Maksim, Brenner, Malcolm K, Atilla, Erden

“…BackgroundC-type lectin-like molecule 1 (CLL-1) is highly expressed in acute myeloid leukemia (AML) but is absent in primitive hematopoietic progenitors,…”
Get full text

Resistance against anti-CD19 and anti-BCMA CAR T cells: Recent advances and coping strategies by Atilla, Pinar Ataca, Atilla, Erden

“…•Some patients may experience resistance to CD19 CAR T cell and BCMA CAR T cell therapies or relapse after treatment.•Mechanisms of resistance to CAR T cell…”
Get full text

CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia by Gomes-Silva, Diogo, Atilla, Erden, Atilla, Pinar Ataca, Mo, Feiyan, Tashiro, Haruko, Srinivasan, Madhuwanti, Lulla, Premal, Rouce, Rayne H., Cabral, Joaquim M.S., Ramos, Carlos A., Brenner, Malcolm K., Mamonkin, Maksim

“…Chimeric antigen receptor (CAR) T cell therapy for the treatment of acute myeloid leukemia (AML) has the risk of toxicity to normal myeloid cells. CD7 is…”
Get full text

Single-cell analysis of the multiple myeloma microenvironment after gamma-secretase inhibition and CAR T-cell therapy by Coffey, David G, Atilla, Pinar Ataca, Atilla, Erden, Landgren, Ola, Cowan, Andrew J, Simon, Sylvain, Pont, Margot, Comstock, Melissa L, Hill, Geoffrey R, Riddell, Stanley R, Green, Damian J

“…Chimeric antigen receptor (CAR) T-cells and bispecific antibodies (BsAb) targeting B-cell maturation antigen (BCMA) have significantly advanced the treatment…”
Get full text

AN OVERVIEW OF HEMATOPOIETIC STEM CELL TRANSPLANTATION RELATED THROMBOTIC COMPLICATIONS by Sahin, Ugur, Atilla, Pinar Ataca, Atilla, Erden, Toprak, Selami Kocak, Demirer, Taner

“…Abstract Thrombotic episodes are far less common than bleeding complications after hematopoietic stem cell transplantation (HSCT). However, they lead to…”
Get full text

How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation? by Ataca Atilla, Pinar, Bakanay Ozturk, Sule Mine, Demirer, Taner

“…Abstract Today, peripheral blood stem cells are the preferred source of stem cells over bone marrow. Therefore, mobilization plays a crutial role in successful…”
Get full text

Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now? by Atilla, Erden, Atilla, Pinar Ataca, Demirer, Taner

“…The management of relapsed/refractory mantle cell lymphoma remains challenging. Patients with relapsed mantle cell lymphoma have been treated with multi-agent…”
Get full text

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations by Atilla, Erden, Ataca Atilla, Pınar, Demirer, Taner

“…Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is a curative treatment option for both malignant and some benign hematological diseases. During…”
Get full text

Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation by Ataca Atilla, Pinar, Akkus, Erman, Atilla, Erden, Gokmen, Neslihan, Civriz Bozdag, Sinem, Kurt Yuksel, Meltem, Toprak, Selami Kocak, Baskal, Nilgun, Akan, Hamdi, Demirer, Taner, Topcuoglu, Pervin, Arslan, Onder, Ilhan, Osman, Ozcan, Muhit, Beksac, Meral, Gurman, Gunhan

“…Introduction Thyroid dysfunction (TD) is one of the major endocrinopathies shown after allogeneic hematopoietic stem cell transplantation over the long term…”
Get full text

Hepatitis B Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Regimens Containing Lenalidomide and/or Bortezomib by Ataca Atilla, Pınar, Yalçıner, Merih, Atilla, Erden, İdilman, Ramazan, Beksaç, Meral

“…Reactivation of the hepatitis B virus (HBV) refers to an increase in HBV replication in a patient with inactive or resolved HBV. In this retrospective study,…”
Get full text

Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS) by Atilla, Erden, Atilla, Pinar Ataca, Bozdag, Sinem Civriz, Yuksel, Meltem Kurt, Toprak, Selami Kocak, Topcuoglu, Pervin, Akay, Bengu Nisa, Sanli, Hatice, Gurman, Gunhan, Ozcan, Muhit

“…Cutaneous T cell lymphoma is a heterogeneous group of lymphoproliferative disorders with different clinical behavior and prognosis in which malignant T cells…”
Get full text

Prospective Analysis of Hemorrhagic Cystitis and BK Viremia in Allogeneic Hematopoietic Stem Cell Transplantation by Atilla, Erden, Ateş, Can, Uslu, Atilla, Ataca Atilla, Pınar, Dolapçı, Istar, Tekeli, Alper, Topçuoğlu, Pervin

“…BK virus (BKV) infection has been shown to be related to hemorrhagic cystitis (HC) in allogeneic hematopoietic stem cell transplantation (allo-HSCT). There are…”
Get full text

Fertility After Allogeneic Hematopoietic Stem Cell Transplantation: A 23-Year Review From A Tertiary Hospital by Atilla, Pinar

Get full text

Are we there yet? cellular therapies for cutaneous T cell lymphoma by Atilla, Pinar Ataca, Atilla, Erden

“…Cutaneous T cell lymphomas (CTCLs) are a heterogenous group of skin-involved T-cell non-Hodgkin lymphoma which Mycosis Fungoides and Sezary Syndrome are the…”
Get full text

A review of late complications of allogeneic hematopoietic stem cell transplantations by Atilla, Erden, Atilla, Pinar Ataca, Toprak, Selami Kocak, Demirer, Taner

“…Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is an effective and curative treatment of different malignant and non‐malignant diseases. Early…”
Get full text

A review of infectious complications after haploidentical hematopoietic stem cell transplantations by Atilla, Erden, Atilla, Pinar Ataca, Bozdağ, Sinem Civriz, Demirer, Taner

“…Background Allogeneic hematopoietic stem cell transplantation from haploidentical donor is a feasible option for patients with hematological diseases who lack…”
Get full text

Trogocytosis May Attenuate the Efficacy of Anti-BCMA CAR T Cells Administered in Combination with γ-Secretase Inhibitor by Ataca Atilla, Pinar, Simon, Sylvain, Atilla, Erden, Comstock, Melissa L, Cowan, Andrew J., Hill, Geoffrey R, Riddell, Stanley R., Green, Damian J

“…Introduction: γ-Secretase inhibitors (GSIs) are proven to reduce shedding and increase BCMA surface density on plasma cells thus enhancing anti-multiple…”
Get full text